Royce & Associates’s Viemed Healthcare VMD Stock Holding History

Royce & Associates’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-63,600	Closed	-$497K	–	1064
2020 Q4	$497K	Sell	63,600 -121,400	-66%	-$1.07M	﹤0.01%	890
2020 Q3	$1.6M	Hold	185,000	–	–	0.02%	718
2020 Q2	$1.77M	Buy	185,000 +99,000	+115%	+$770K	0.02%	692
2020 Q1	$404K	Sell	86,000 -80,000	-48%	-$397K	0.01%	855
2019 Q4	$1.04M	Buy	166,000 +63,000	+61%	+$437K	0.01%	806
2019 Q3	$711K	Buy	+103,000	New	+$686K	0.01%	851

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates's VMD Position: Q1 2021 in Review

Royce & Associates sold out of Viemed Healthcare (VMD) in Q1 2021, closing a stake of 63,600 shares — an estimated $497K sold.

Royce & Associates first reported a position in VMD in Q3 2019 and held it in 6 quarters. The position peaked at $1.77M in Q2 2020. 100 funds tracked by Wall St. Rank hold VMD as of Q1 2021.

Royce & Associates reported no remaining Viemed Healthcare position as of Q1 2021 after selling out during the quarter.
Royce & Associates sold 63,600 Viemed Healthcare shares in Q1 2021, an estimated $497K.
Royce & Associates first reported a position in Viemed Healthcare in Q3 2019 and held it in 6 quarters.
Royce & Associates's Viemed Healthcare position peaked at $1.77M in Q2 2020.
100 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2021.

Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.